Assignee
GLENN JEFFREY S
US·5 granted patents·7 pending applications·29 citations·filing 1992–2020
Top patents by PatentIndex Score
12 records- 0190US8663648B2Agents for treatment of HCV and methods of useGLENN JEFFREY S·Filed 2011·Granted Mar 4, 2014·11 cites·15 claims
- 0288US8093353B2Agents for treatment of HCV and methods of useGLENN JEFFREY S·Filed 2007·Granted Jan 10, 2012·11 cites·29 claims
- 0370US8940730B2Methods and compositions of treating a Flaviviridae family viral infectionGLENN JEFFREY S·Filed 2010·Granted Jan 27, 2015·1 cites·59 claims
- 0469US2008214471A1Method for inhibition of viral infectionGLENN JEFFREY S·Filed 2007·Application pending·0 cites
- 0561US2006040259A1Method for inhibition of viral infectionGLENN JEFFREY S·Filed 2004·Application pending·0 cites
- 0657US2006248606A1Mouse model for hepatitis CGLENN JEFFREY S·Filed 2006·Application pending·0 cites
- 0754US2011262565A1PIP-2 Inhibition-Based Antiviral and Anti-Hyperlipidemic TherapiesGLENN JEFFREY S·Filed 2009·Application pending·0 cites
- 0852US2011217265A1Screening for Inhibitors of HCV Amphipathic Helix (AH) FunctionGLENN JEFFREY S·Filed 2009·Application pending·0 cites
- 0949US8871435B2Methods and compositions for identifying agents that inhibit an NS4B-mediated neoplastic cellular phenotype of HCV infected cellsGLENN JEFFREY S·Filed 2008·Granted Oct 28, 2014·0 cites·18 claims
- 1048US2022062243A1P14-Kinase Inhibitors with Anti-Cancer ActivityGLENN JEFFREY S·Filed 2020·Application pending·0 cites
- 1141US5503973AMethod for inhibition of viral morphogenesisGLENN JEFFREY S·Filed 1992·Granted Apr 2, 1996·6 cites·6 claims
- 1237US2013288917A1Rapid High Resolution, High Throughput RNA Structure, RNA-Macromolecular Interaction, and RNA-Small Molecule Interaction MappingGLENN JEFFREY S·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →